Evoq Remedies IPO vs Shigan Quantum Technologies IPO

Comparison between Evoq Remedies IPO and Shigan Quantum Technologies IPO.

IPO Details

Evoq Remedies IPO is a SME Fixed Price IPO proposed to list at BSE SME while Shigan Quantum Technologies IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Evoq Remedies IPO is up to ₹9.23 Cr whereas the issue size of the Shigan Quantum Technologies IPO is up to ₹21.56 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of Shigan Quantum Technologies IPO is ₹50.00 per share.

 Evoq Remedies IPOShigan Quantum Technologies IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹27.00 per share₹50.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size4000 shares3000 shares
Fresh Issue Size34,20,000 shares43,11,000 shares
Fresh Issue Size (Amount)up to ₹9.23 Crup to ₹21.56 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total34,20,000 shares43,11,000 shares
Issue Size Total (Amount)up to ₹9.23 Crup to ₹21.56 Cr

IPO Timetable

Evoq Remedies IPO opens on Mar 17, 2022, while Shigan Quantum Technologies IPO opens on Feb 28, 2022. The closing date of Evoq Remedies IPO and Shigan Quantum Technologies IPO is Mar 22, 2022, and Mar 03, 2022, respectively.

 Evoq Remedies IPOShigan Quantum Technologies IPO
Issue OpenMar 17, 2022Feb 28, 2022
Issue CloseMar 22, 2022Mar 03, 2022
Basis Of Allotment (Tentative)Mar 25, 2022Mar 08, 2022
Initiation of Refunds (Tentative)Mar 28, 2022Mar 09, 2022
Credit of Share (Tentative)Mar 29, 2022Mar 10, 2022
Listing date (Tentative)Mar 30, 2022Mar 11, 2022

Financials & KPIs

Evoq Remedies IPO P/E ratio is 33.75, as compared to Shigan Quantum Technologies IPO P/E ratio of 12.41.

 Evoq Remedies IPOShigan Quantum Technologies IPO
Financials

Company Financials (Restated)

Period Ended10 Feb 202231 Mar 202131 Mar 202031 Mar 2019
Assets26.618.055.652.15
Total Income10.5710.029.073.25
Profit After Tax0.940.710.000.01
EBITDA1.250.950.000.02
NET Worth13.280.740.020.02
Reserves and Surplus3.280.730.010.01
Total Borrowing5.730.010.010.00
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Aug 202131 Mar 202131 Mar 202031 Mar 2019
Assets46.7945.3024.7322.06
Total Income64.4096.0272.7969.08
Profit After Tax2.893.512.922.66
EBITDA4.677.055.154.96
NET Worth19.7516.8613.348.20
Reserves and Surplus17.2114.3210.816.20
Total Borrowing1.778.776.866.89
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)99.99%100%
Promoter Shareholding (Post-Issue)73.53%73.63%
P/E Ratio33.7512.41
Market Cap₹36.72 Cr.₹86.08 Cr.
Debt/Equity0.09
EPS₹10.05₹2.77
RoNW96.9420.84

Shares Offered

In the Evoq Remedies IPO Retail Individual Investors (RII) are offered 17,10,000 shares while in Shigan Quantum Technologies IPO retail investors are offered 17,10,000 shares. Qualified Institutional Buyers (QIB) are offered in Evoq Remedies IPO and in Shigan Quantum Technologies IPO.

 Evoq Remedies IPOShigan Quantum Technologies IPO
Market Maker Reservation1,80,000 shares2,28,000 shares
NII17,10,000 shares21,54,000 shares
RII17,10,000 shares21,57,000 shares
Total34,20,000 shares43,11,000 shares

Bids Received (Subscription)

Evoq Remedies IPO subscribed 1.67x in total, whereas Shigan Quantum Technologies IPO subscribed 17.95x.

 Evoq Remedies IPOShigan Quantum Technologies IPO
NII (times)0.30x27.70x
RII (times)3.03x8.21x
Total (times)1.67x17.95x

Compare with others

Compare:

Evoq Remedies IPO Vs Shigan Quantum Technologies IPO